Medication Reconciliation and Reducing Adverse Drug Events Regional - - PowerPoint PPT Presentation

medication reconciliation and reducing adverse drug events
SMART_READER_LITE
LIVE PREVIEW

Medication Reconciliation and Reducing Adverse Drug Events Regional - - PowerPoint PPT Presentation

Medication Reconciliation and Reducing Adverse Drug Events Regional Learning & Action Network Meetings 2017 Importance of Getting Medication Management Right Pharmaceuticals are the most common medical intervention, and their potential


slide-1
SLIDE 1

Medication Reconciliation and Reducing Adverse Drug Events

Regional Learning & Action Network Meetings 2017

slide-2
SLIDE 2

“Pharmaceuticals are the most common medical intervention, and their potential for both help and harm is enormous. Ensuring that the American people get the most benefit from advances in pharmacology is a critical component of improving the national health care system.”

  • The Institute of Medicine (IOM), 2007

The Institute of Academy of Sciences. Informing the future: Critical issues in health. Fourth edition, page 13. http://www.nap.edu/catalog/12014.html

Importance of Getting Medication Management Right

slide-3
SLIDE 3

Building the Case

3

1999 Institute of Medicine (IOM) report

  • To Err is Human
  • 44,000–98,000 people die each year as a direct result of

medical errors 2006 IOM report

  • Preventing Medication Errors
  • 400,000 preventable drug-related injuries occur in U.S.

hospitals each year, each costing about $8,750

Journal for Healthcare Quality

  • Vol. 36, No. 6, pp. 58–68 C 2014 National

Association for Healthcare Quality

slide-4
SLIDE 4

Building the Case (cont.)

4

2010 U.S, Office of Inspector General

  • 44 percent hospital adverse events were preventable
  • The most common preventable adverse events were related

to medications (42 percent)

Journal for Healthcare Quality

  • Vol. 36, No. 6, pp. 58–68 C 2014 National

Association for Healthcare Quality

slide-5
SLIDE 5

Building the Case (cont.)

5

2014 Annals of Pharmacotherapy

28 to 60 percent of ADEs leading to hospital admission are preventable

2001 Pharmacoepidemiology and Drug Safety

Emergency hospitalizations for recognized ADEs in older adults most

  • ften result from warfarin, insulin, antiplatelet and oral hypoglycemic

agents

2002 Annals of Pharmacotherapy

Patients rehospitalized within 30 days have more complex medication regimens

Willson MN, et al. Medication regimen complexity and hospital readmission for an adverse drug event. Ann Pharmacotherapy. 2014 Jan;48(1):26-32. Jha AK, et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiology Drug Saf. 2001 Mar-Apr;10(2):113-9. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacotherapy. 2002 Sep;36(9):1331-6.

slide-6
SLIDE 6

Adverse Drug Events (ADEs)

slide-7
SLIDE 7

Medication Safety Definitions

Term Definition Example Adverse Drug Event (ADE) INJURY resulting from medical intervention related to a drug. Most are preventable. Bleeding from Coumadin

  • verdose.

Adverse Drug Reaction (ADR) Harm directly caused by a drug at usual

  • doses. Causal link between the drug and

the harm. Allergic reaction. Medication Error Inappropriate use of a drug that may or may not cause harm. Preventable. Patient receives wrong medication. Potential Adverse Drug Event (pADE) Medication error that could potentially lead to ADE, stopped before harm can

  • ccur.

Patient has an order for a medication to which he/she is allergic, order changed before patient takes the medication.

slide-8
SLIDE 8

ADEs, Hospital Utilization and 30 Day Readmissions

8

slide-9
SLIDE 9

Medication Related Problems (MRP)

Practitioners Patient Drug

Activity

  • Age specific dosing adjustment
  • Substance Abuse & Misuse
  • Lack of engagement of patient and

family in D/C plan

  • Lack of communication during

transitions in care

  • Duplicate therapy
  • Pharmacogenomics
  • Adverse reactions
  • Medication reconciliation not done
  • Patient sent home with an incorrect list
  • Interaction from multi-prescribers (Rx, OTC,

Herbal, Foods, etc.) not assessed Drug/Dose

  • Misinformation-EMR and Med list does not

match

  • Provider does not know if script filled
  • Cost
  • Access
  • Availability
  • Therapeutic Drug Monitoring
  • Clinical status changes
  • Compliance & Adherence (pt. fails teach back)
  • Prescribing error
  • Dispensing error
slide-10
SLIDE 10

Medication Management

10

Reconcile medications on admission with input from patient and family at all levels of care (Home, Home Health, SNF, NH, Hospice, Assisted living etc..) Resolve discrepancies such as omissions, duplications, adjustments, deletions, and additions to the medication list during hospital stay Provide the most current list of medications to the next care provider Assess patient’s ability or inability to name medications, their purpose and how and when to take the medication and know any special precautions listed in the record

slide-11
SLIDE 11

Medication Management

11

Alert and educate family/caregiver if patient is unable to name medications and purpose, Discuss patient needs with next care provider set up planned follow-up Refer patients with more than five medications or more than two medication changes during hospitalization for pharmacy/ medication management follow-up Discuss opting out of scheduled refills and automatic refills until medications are reconciled with pharmacist

slide-12
SLIDE 12

Medication Management (cont.)

12

Refer patients with complex medications to the pharmacy for

  • utpatient education, medication review, follow-up calls and in

home visits OTHER Interventions??? http://www.rarereadmissions.org/areas/ medmanagement.html

slide-13
SLIDE 13

Quality Measures (7)

13

Reduction in statewide Adverse Drug Events Reduction in statewide Readmissions for beneficiaries at High Risk* for an adverse drug event related to

  • Anticoagulant medications;
  • Diabetic medications;
  • Opioid medications

Reduction in statewide Hospital Utilization (Admissions, ER

  • r Observations) for beneficiaries at High Risk* for an adverse

drug event related to

  • Anticoagulant medications;
  • Diabetic medications;
  • Opioid medications

*Taking three medications plus an anticoagulant , diabetic or

slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16
slide-17
SLIDE 17
slide-18
SLIDE 18

Integrating Medication Reconciliation and ADE Prevention

18

Medication reconciliation at each new encounter Reduce the number of potentially inappropriate medications Decrease the risk of an ADE through better communication and patient/family education/engagement/empowerment Focus on the three high risk medications: Opioid, Anticoagulant, and Diabetic

slide-19
SLIDE 19

State opioid prescribing rates vary up to 3-fold

19

slide-20
SLIDE 20

Factors driving overuse of opioids

20

Knowledge gaps:

  • Overestimation of effectiveness for chronic pain
  • Underestimation of opioid use disorder and overdose risks
  • Lack of familiarity with non-opioid treatments

Insufficient access to non-opioid treatments Patient requests for opioids Time pressure; It takes time

  • to explain why opioids are not the best treatment
  • to arrange non-opioid treatment
slide-21
SLIDE 21

Opioid Medication Patient Education

21

Fact sheets-What You need to Know Posters PowerPoint Presentations Brochures Pocket cards Checklist

https://www.cdc.gov/drugoverdose/prescribing/patient-tools.html

slide-22
SLIDE 22

Anticoagulation Medication Patient Education

22

Excessive anticoagulation with warfarin

  • Increase “in control” INR
  • Testing at least every 30 days

Anticoagulation Clinic UC San Diego Health

  • http://bit.ly/2xTXLVh

Anticoagulation Centers of Excellence

  • http://bit.ly/2jbkhp3

American Heart Association

  • http://bit.ly/2wPzD67
slide-23
SLIDE 23

Diabetic Medication Patient Education

23

Hypoglycemia in persons receiving insulin

  • Increase “in control” A1c
  • Testing every three months

Mississippi Diabetes Association | http://bit.ly/2wNHlzS American Diabetes Association | http://bit.ly/1m4ONGx Diabetes Forecast-Type 2 Diabetic Medications | http://bit.ly/2xbrfju

slide-24
SLIDE 24
slide-25
SLIDE 25

25

slide-26
SLIDE 26

Contact Information

26

Join the community coalition near you and serve on the Medication Safety workgroup Mary Helen Conner, PhD, MPH, BSN, RN, MCHES Mary.conner@area-g.hcqis.org Quality Improvement Advisor 1-601-957-1575 ext. 219